Add-on biologic a boon for kids with moderate to severe asthma: study
Fortnightly dupilumab with standard therapy leads to rapid and sustained improvements in asthma control for 6-11 year-olds with moderate to severe type 2 asthma, research…
Tag: Biologics
Biologic safer than systemic corticosteroids for pemphigoid: study
The monoclonal antibody rituximab is just as effective as systemic corticosteroids in treating patients with pemphigoid, but is associated with fewer adverse events, according to…
A GP guide to severe asthma in adults
Need to know: Asthma is a heterogeneous disease characterised by chronic airway inflammation, reversible expiratory airflow limitation and airway hyper-responsiveness.1 × Welcome to AusDoc. Enabling…
Drug combination ‘boosts therapy success’ in Crohn’s disease
New studies provide clarity on the benefits of using the monoclonal antibody vedolizumab plus thiopurines in inflammatory bowel disease.
A GP guide to genomics in cancer treatment
The rapid development of genomics technologies and their introduction into the clinical setting has resulted in an explosion of knowledge.
Low-dose rituximab ‘dampens disease activity’ in pemphigus
Australian dermatologists report a case series of eight patients with mild disease.
So what are ‘needle pills’ and why would doctors use them?
A tortoise has inspired an experimental drug-delivery device.
Subcutaneous vedolizumab ‘effective for maintenance’ in Crohn’s disease
Patients responsive to the IV formulation may find subcutaneous dosing more convenient, expert says.
Prescribing changes ‘crucial’ to manage tocilizumab shortage
The biologic has become scarce worldwide because of its use for COVID-19, the manufacturer says.
Viral-vector vaccines ‘likely best with rituximab’
Researchers recommend COVID-19 vaccines associated with low release of interferon for B cell-depleted patients.
